BNP/CALL/MERCK & CO./130/0.1/17.01.25 Share Price

Warrant

DE000PE89AL5

Market Closed - Deutsche Boerse AG 20:50:25 12/06/2024 BST
0.85 EUR -10.53% Intraday chart for BNP/CALL/MERCK & CO./130/0.1/17.01.25
1 month-10.53%
3 months+30.77%
Date Price Change
12/06/24 0.85 -10.53%
11/06/24 0.95 +2.15%
10/06/24 0.93 +5.68%
07/06/24 0.88 +1.15%
06/06/24 0.87 +2.35%

Delayed Quote Deutsche Boerse AG

Last update June 12, 2024 at 08:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE89AL
ISINDE000PE89AL5
Date issued 16/02/2023
Strike 130 $
Maturity 17/01/2025 (219 Days)
Parity 10 : 1
Emission price 0.61
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.21
Lowest since issue 0.14
Spread 0.01
Spread %1.16%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
142.7 USD
Spread / Average Target
+9.59%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW